Wells Fargo’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-116,487
| Closed | -$6.11M | – | 7442 |
|
|
2020
Q3 | $6.11M | Sell |
116,487
-80,208
| -41% | -$3.32M | ﹤0.01% | 2332 |
|
|
2020
Q2 | $6.54M | Sell |
196,695
-32,543
| -14% | -$1.04M | ﹤0.01% | 2216 |
|
|
2020
Q1 | $6.24M | Buy |
229,238
+43,324
| +23% | +$1.21M | ﹤0.01% | 2061 |
|
|
2019
Q4 | $3.67M | Buy |
185,914
+122,996
| +195% | +$1.97M | ﹤0.01% | 2838 |
|
|
2019
Q3 | $815K | Buy |
62,918
+8,597
| +16% | +$104K | ﹤0.01% | 4002 |
|
|
2019
Q2 | $677K | Sell |
54,321
-78,377
| -59% | -$1.04M | ﹤0.01% | 4172 |
|
|
2019
Q1 | $1.93M | Buy |
132,698
+10,114
| +8% | +$129K | ﹤0.01% | 3389 |
|
|
2018
Q4 | $1.35M | Sell |
122,584
-114,067
| -48% | -$1.59M | ﹤0.01% | 3606 |
|
|
2018
Q3 | $6.22M | Buy |
236,651
+8,710
| +4% | +$235K | ﹤0.01% | 2472 |
|
|
2018
Q2 | $4.66M | Sell |
227,941
-9,542
| -4% | -$205K | ﹤0.01% | 2753 |
|
|
2018
Q1 | $4.31M | Sell |
237,483
-10,466
| -4% | -$174K | ﹤0.01% | 2754 |
|
|
2017
Q4 | $3.46M | Buy |
247,949
+28,429
| +13% | +$384K | ﹤0.01% | 2914 |
|
|
2017
Q3 | $4.06M | Buy |
219,520
+13,921
| +7% | +$233K | ﹤0.01% | 2707 |
|
|
2017
Q2 | $3.48M | Buy |
205,599
+11,789
| +6% | +$179K | ﹤0.01% | 2743 |
|
|
2017
Q1 | $2.59M | Sell |
193,810
-16,380
| -8% | -$257K | ﹤0.01% | 2994 |
|
|
2016
Q4 | $3.16M | Buy |
210,190
+44,197
| +27% | +$584K | ﹤0.01% | 2773 |
|
|
2016
Q3 | $1.94M | Sell |
165,993
-7,192
| -4% | -$84.6K | ﹤0.01% | 2993 |
|
|
2016
Q2 | $1.87M | Buy |
173,185
+29,181
| +20% | +$301K | ﹤0.01% | 3028 |
|
|
2016
Q1 | $1.33M | Buy |
144,004
+33,704
| +31% | +$363K | ﹤0.01% | 3214 |
|
|
2015
Q4 | $1.64M | Buy |
110,300
+85,813
| +350% | +$1.44M | ﹤0.01% | 3136 |
|
|
2015
Q3 | $402K | Sell |
24,487
-3,930
| -14% | -$80.4K | ﹤0.01% | 4085 |
|
|
2015
Q2 | $649K | Buy |
28,417
+18,998
| +202% | +$378K | ﹤0.01% | 3926 |
|
|
2015
Q1 | $143K | Buy |
9,419
+4,452
| +90% | +$57.8K | ﹤0.01% | 4586 |
|
|
2014
Q4 | $60K | Sell |
4,967
-39,191
| -89% | -$448K | ﹤0.01% | 4947 |
|
|
2014
Q3 | $501K | Buy |
44,158
+31,224
| +241% | +$356K | ﹤0.01% | 3897 |
|
|
2014
Q2 | $156K | Buy |
12,934
+12,734
| +6,367% | +$150K | ﹤0.01% | 4488 |
|
|
2014
Q1 | $2K | Hold |
200
| – | – | ﹤0.01% | 5711 |
|
|
2013
Q4 | $4K | Sell |
200
-100
| -33% | -$1.68K | ﹤0.01% | 5440 |
|
|
2013
Q3 | $4K | Hold |
300
| – | – | ﹤0.01% | 5352 |
|
|
2013
Q2 | $5K | Buy |
+300
| New | +$3.96K | ﹤0.01% | 5227 |
|
Wells Fargo's MNTA Position: Q4 2020 in Review
Wells Fargo sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 116,487 shares — an estimated $6.11M sold.
Wells Fargo first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $6.54M in Q2 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Wells Fargo reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Wells Fargo sold 116,487 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $6.11M.
- Wells Fargo first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Wells Fargo's Momenta Pharmaceuticals, Inc. position peaked at $6.54M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Wells Fargo's 13F filing for Q4 2020, filed 9 Feb 2021.